Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00539162 · ClinicalTrials.gov registry record · NA
Use of the CA 125 Algorithm for the Early Detection of Ovarian Cancer in Low Risk Women
A NA study of Ovarian Cancer, sponsored by M.D. Anderson Cancer Center.
- Recruiting
- Registry status
- NA
- Development phase
- 8,000
- Enrollment target
- 11
- Study locations
NCT00539162 is a NA study of Ovarian Cancer that is actively recruiting participants, run by M.D. Anderson Cancer Center. The registered enrollment target is 8,000 participants, above the 704-participant average among 322 other Ovarian Cancer trials with a reported enrollment target (1036% higher). The trial reports 11 study locations across 7 states.
The verdict
NCT00539162, a NA study of Ovarian Cancer, is actively recruiting participants, sponsored by M.D. Anderson Cancer Center.
- RECRUITING
- Registry status
- NA
- Development phase
- 8,000 participants
- Enrollment target
- 11
- Study locations
Study Summary
The goal of this clinical research study is to evaluate a method involving 4 blood tests called CA-125, HE4, HE4 antigen autoantibody complexes, and osteopontin that may be helpful in the early detection of ovarian cancer in women who are at low risk.
Conditions Studied
Interventions
- BEHAVIORAL Questionnaire
Study Locations (11)
Texas
- The University of Texas at Austin - Austin
- University of Texas (UT) Southwestern Medical Center - Dallas
- University of Texas MD Anderson Cancer Center - Houston
- Women's Hospital of Texas, Obstetrics and Gynecology Associates (OGA) - Houston
- UT Health Science Center San Antonio - San Antonio
Florida
- Sylvester Comprehensive Cancer Center, Univ of Miami Miller School of Medicine - Miami
Iowa
- John Stoddard Cancer Center - Des Moines
New Jersey
- Carol G. Simon Cancer Center / Atlantic Health - Morristown
New York
- University of Rochester Medical Center - Rochester
Oklahoma
- University of Oklahoma Health Sciences Center - Oklahoma City
Rhode Island
- Women's and Infant's Hospital - Providence
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 8,000 participants |
| Start Date | 2001-07-02 |
| Est. Completion | 2028-11-30 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00539162
The ClinicalTrials.gov registry entry for NCT00539162 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 8,000 participants, a figure that helps gauge the scale of data the investigators plan to collect, above the 704-participant average among 322 other Ovarian Cancer trials with a reported enrollment target (1036% higher). The listed sponsor is M.D. Anderson Cancer Center, which has 2,692 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Ovarian Cancer appearing as the primary indexed condition, and to 1 intervention - of which Questionnaire is the first listed.
NCT00539162 reports 11 study locations spanning 7 distinct geographic areas - top geographies include Texas, Florida, Iowa.
Frequently Asked Questions
What is clinical trial NCT00539162 about?
NCT00539162 is a clinical study titled "Use of the CA 125 Algorithm for the Early Detection of Ovarian Cancer in Low Risk Women". The goal of this clinical research study is to evaluate a method involving 4 blood tests called CA-125, HE4, HE4 antigen autoantibody complexes, and osteopontin that may be helpful in the early detection of ovarian cancer in women who are at low risk.
What is the current status of trial NCT00539162?
This trial is currently recruiting. It is a NA study. The enrollment target is 8,000 participants. The study started on 2001-07-02. Estimated completion is 2028-11-30.
What conditions does trial NCT00539162 study?
This clinical trial studies the following conditions: Ovarian Cancer.
What interventions are being tested in trial NCT00539162?
The interventions under investigation include: Questionnaire (BEHAVIORAL).
Who is sponsoring clinical trial NCT00539162?
This trial is sponsored by M.D. Anderson Cancer Center, which has 2,692 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00539162 being conducted?
This trial has 11 study locations across Florida, Iowa, New Jersey, New York, Oklahoma. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Ovarian Cancer
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Pilot Randomized Controlled Trial of a Collaborative Agenda-setting Intervention (CASI) for Patients With Ovarian Cancer
RECRUITING · NA
-
ASk Questions in GYnecologic Oncology (ASQ-GYO)
RECRUITING · NA
-
A Study Evaluating the Integrative Medicine at Home (IM@HOME) Program in People With Cancer
RECRUITING · NA
-
REVITALIZE: RCT to Reduce Fatigue in Adults With Ovarian Cancer on PARP Inhibitors
RECRUITING · NA
-
Evaluating an Evidence-Based Family History Screening Program Adapted to Increase Reach and Uptake of Screening for BRCA-Associated Cancers in Rural Public Health Clinics
RECRUITING · NA
-
Comprehensive Yoga Therapy Based Lifestyle Prehabilitation Program for Women With Ovarian Cancer
RECRUITING · NA
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.